↓ Skip to main content

FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy

Overview of attention for article published in Frontiers in oncology, November 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
2 Mendeley